What is CAGR? What does CAGR table indicate for Shukra Pharmaceuticals Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Shukra Pharmaceuticals Ltd Stock Analysis

Q: Is Shukra Pharmaceuticals Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Shukra Pharmaceuticals Ltd and arrived at the following conclusion.

Q: What is Shukra Pharmaceuticals Ltd share price return in the past 10 years?

We analysed the performance of Shukra Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Small Cap

Evaluated by 34 users | BSE: 524632 | NSE: |
Pharmaceuticals & Drugs

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Return on Capital Employed	10.26%	14.86%	-6.57%	-9.09%	-6.25%	-1.05%	3.43%	3.52%	3.35%	2.31%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	8.6	9.9	6.6	5.1	4.4	2.6	4.8	5.1	5.3	5.7
Y-o-Y Gr. Rt.	-	14.3%	-32.8%	-22.9%	-13.3%	-41.8%	87.2%	6.4%	3.9%	6%
Adjusted EPS (Rs.)	0.24	0.59	-0.5	-0.85	-4.82	-0.99	3.2	3.2	3.37	2.95
Y-o-Y Gr. Rt.	-	145.8%	-184.8%	NA	NA	NA	NA	0%	5.3%	-12.5%
Book Value per Share (Rs.)	-0.18	0.58	1.64	-0.42	88.29	89.13	89.89	93.1	95.86	98.2
Adjusted Net Profit	0.3	0.7	-0.6	-1	-0.8	-0.2	0.5	0.5	0.5	0.5
Net Op. Cash Flow (Rs. Cr.)	0.1	1.6	-7.1	10.4	-3.1	-2	2.7	-0.3	0.8	0.3
Debt to Cash Flow from Ops	109.8	3.19	-1.47	0.97	-0.1	-0.59	0.01	-0.12	4.28	23.38

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Shukra Pharmaceuticals Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Shukra Pharmaceuticals Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	-4.6%	5%	5.4%	6%
Adjusted EPS	32.2%	NA	-2.7%	-12.5%
Book Value per Share	0	2.2	3	2.4
Share Price	31.2%	-4.9%	-11.9%	-15.1%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Return on Equity (%)	-94.33	392.22	-59.68	-193.34	-11.26	-1.12	3.57	3.5	3.57	3.04
Operating Profit Margin (%)	11.21	11.26	4.33	10.09	-2.11	-9.58	24.54	28.51	30.23	29.14
Net Profit Margin (%)	3.33	7.12	-8.96	-19.71	-17.01	-6.03	10.38	9.75	9.88	8.16
Debt to Equity	-36.19	10.07	7.12	-23.49	0.02	0.09	0	0	0.24	0.39
Working Capital Days	289	277	612	601	390	879	392	379	467	526
Cash Conversion Cycle	109	74	161	179	90	165	75	64	31	40

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	49.17%
Institutions	0.80%
Non-Institutions	50.04%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Shukra Pharmaceuticals Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Shukra Pharmaceuticals Ltd a good price to buy it?

The 5-year analysis of Shukra Pharmaceuticals Ltd's performance infers:

Shukra Pharmaceuticals Ltd earnings have grown by 0%, whereas share price has depreciated -4.9% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

3. What is Shukra Pharmaceuticals Ltd share price return in the past 10 years ?

Data is not available for this company

About Company

No data to display